We next examined E-cadherin protein levels in response to treatment with niclosamide and pyrvinium, and found that the treatments of nM levels of niclosamide and pyrvinium increased E-cadherin protein abundances in osteosarcoma cells (Figure 4A). The gene discussed is CDH1; the disease is osteosarcoma.